Catapult centres to stimulate UK innovation and growth

Published: 9-Dec-2011
Research & Development Finance

Established with £200m of government funding


The UK’s Technology Strategy Board (TSB) has revealed the name for an elite network of six technology and innovation centres that will be established by summer 2013.

The £200m Catapult centres are expected to drive economic growth by closing the gap between concept and commercialisation and enhance innovation in specific technology areas.

The TSB says the centres will be business-focused, supporting SMEs and large enterprises as part of a co-ordinated investment in innovation.

The Catapult centre in High-Value Manufacturing opened in October, with Cell Therapy and Offshore Renewable Energy on track to open in 2012. Three more Catapults will be selected from ten potential technology areas and announced early next year.

See more

You may also like

Manufacturing

Innovate UK partners with UK government to bolster medicines manufacturing

Read more
Innovate UK and the Department of Health and Social Care aim to enhance the UK medicines manufacturing sector through investment and collaboration — supporting startups and small companies to drive innovation in the sector

Trending Articles

  1. Douglas Pharmaceuticals sets new benchmark for capsule quality with CI Precision Partnership delivers compliance confidence, efficiency gains and reduced waste
  2. Almac expands bioavailability capabilities to address a critical need in drug development Almac Group has completed a multimillion-pound expansion of its bioavailability enhancement capabilities at its facility in Charnwood, UK
  3. Servier acquires potential treatment for Fragile X syndrome KER-0193, a novel, orally bioavailable small molecule, was granted orphan drug and rare paediatric drug designation by the US FDA
  4. NICE recommends enfortumab vedotin with KEYTRUDA for adults in England/Wales with untreated metastatic urothelial cancer The results from the Phase III study EV-302/KN-A39 showed nearly a doubling of survival rates in patients compared with those who received platinum-based chemotherapy, which is the current standard of care in the UK
  5. Fidia Farmaceutici enters the UK market with the acquisition of Altacor Marking another significant milestone in its ongoing international expansion, the company enters the rapidly growing UK ophthalmology market, a key therapeutic area for the group

Upcoming event

Enhancing probiotic stability through smarter formulation and packaging strategies

18 September 2025 | Virtual See all

You may also like

Manufacturing

Innovate UK partners with UK government to bolster medicines manufacturing

Innovate UK and the Department of Health and Social Care aim to enhance the UK medicines manufacturing sector through investment and collaboration — supporting startups and small companies to drive innovation in the sector
Research & Development

New centres of excellence for regulation announced to accelerate life-saving innovations

Pioneering use of artificial intelligence (AI) could cut the time it takes to bring life-saving treatments to patients
Manufacturing

Innovate UK awards Stablepharma grant to advance fridge-free vaccine

Innovate UK has awarded Stablepharma a grant to advance its lead candidate SPVX02, a fridge-free vaccine for the prevention of Tetanus and Diphtheria
Research & Development

Intellegens secures $2m to support research of oligonucleotide therapeutic manufacture

In collaboration with CPI, Intellegens has secured a grant from Innovate UK to fund a two year project to augment technology that will assist productivity and yields of oligonucleotide therapeutic manufacture
Finance

Start-up receives Innovate UK funding for intraocular lens implant

Cataract is the most common cause of treatable blindness worldwide and is treated with surgery, however there is risk of postoperative inflammation
Finance

Innovate UK funds biologics manufacturing consortium

This project aims to address challenges faced in the pharmaceutical industry by increasing flexibility and sustainability, and reducing batch failures
Finance

Ingenza receives grant from Eureka and Innovate UK

The grant will support Ingenza as it aims to build a commercially viable <i>P. putida</i> bio-manufacturing pipeline
Subscribe now